Efficacy and safety of timolol and latanoprost in the treatment of primary open-angle glaucoma

[...]the goal of glaucoma therapy is to lower IOP, and ocular hypotensive agents have the potential to prevent optic nerve damage and preserve vision. [16-18] This might be due to the decline in retinal ganglion cell number and reduced neural capacity. [...]in older individuals, fewer ganglion cells need to be lost before there is detectable visual field loss. [...]latanoprost was found to be a more potent and effective ocular hypotensive than timolol. [...]latanoprost is a preferable and effective option for the management of POAG.